Processes and Issues for Improving Access to Medicines: The evidence base for domestic production and greater access to medicines

HSRC REPORT: This study extrapolates empirical cost data from Sub-saharan African firms to consider the conditions under which domestic production of drugs in a facility in Sub-saharan Africa would be feasible and profitable as a business enterprise, while at the same time, able to promote better access to quality medicines, at a price more affordable than international prices for local consumers.


file type iconDOWNLOAD [537 KB]

Leave a Reply

Your email address will not be published. Required fields are marked *

file type iconDOWNLOAD [537 KB]